在神经母细胞瘤子集中,ONC201的致癌作用超出了其对线粒体的干扰作用
Jyun-Hong Jiang1,2, Yu-Han Lin2, Pei-Lin Liao1,2
1Department of Pediatric Surgery, Kaohsiung Chang Gung Memorial Hospital, Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Kaohsiung, Taiwan.
Journal of molecular medicine (Berlin, Germany)
|April 10, 2025
概括
在非MYCN增强神经母细胞瘤的动物模型中,ONC201没有降低瘤生长. 该药物增加了瘤标记物,并减少了瘤抑制剂,表明超出线粒体点的复杂效应.
科学领域:
- 儿科瘤学 儿科瘤学
- 分子治疗学分子治疗学
- 癌症生物学 癌症生物学
背景情况:
- 神经母细胞瘤 (NB) 在儿科瘤学中是一个重大挑战.
- 一种伊米普里的ONC201显示出抗癌潜力,特别是在MYCN增强的NB中.
- 在非MYCN放大NB中ONC201的有效性需要进一步调查.
研究的目的:
- 评估ONC201在非MYCN放大神经母细胞瘤模型中的疗效.
- 调查ONC201在这种亚型中的作用背后的分子机制.
- 为了确定ONC201的行为是否仅仅依赖于线粒体点.
主要方法:
- 使用非MYCN放大NB细胞系 (SK-N-AS,SK-N-FI) 的动物模型.
- 评估瘤生长,新血管化和关键分子标记物的表达 (c-Myc,LGR5,ATRX).
- 在Rho零 (ρ0) -SK-N-AS细胞中研究作用,以探索线粒体独立性.
主要成果:
- 在非MYCN放大NB模型中,ONC201未能降低瘤生长.
- ONC201诱导了瘤标记物c-Myc和LGR5,同时降低了瘤抑制剂ATRX的调节.
- ONC201没有减弱瘤新血管化,并且在p0细胞中显示了类似的分子趋势.
结论:
- 在缺乏MYCN增强的神经母细胞瘤中,ONC201单疗可能不有效.
- 药物的作用包括调节致癌和瘤抑制途径.
- 了解特定的分子特征对于NB的ONC201治疗决定至关重要.
相关概念视频
01:33Cancer-Critical Genes I: Proto-oncogenes
8.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.6K
01:06Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
01:20The Retinoblastoma Gene
4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
01:46Electron Transport Chain: Complex I and II
9.6K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
9.6K